Pharmaceuticals, Biotechnology and Life Sciences
PRESS RELEASE Immunocore Announces Upcoming Presentations at the 2021 American Society of Clinical Oncology (ASCO) Annual Meeting Overall survival benefit…
PRINCETON, N.J., April 28, 2021 (GLOBE NEWSWIRE) — Advaxis, Inc. (Nasdaq: ADXS), a clinical-stage biotechnology company focused on the development…
Monthly information regarding the total number of voting rights and total number of shares of the Company (Article 223-16…
WESTLAKE VILLAGE, Calif., April 28, 2021 (GLOBE NEWSWIRE) — Arcutis Biotherapeutics, Inc. (Nasdaq: ARQT), a late-stage biopharmaceutical company focused on…
CAMBRIDGE, Mass., April 28, 2021 (GLOBE NEWSWIRE) — Checkmate Pharmaceuticals Inc. (NASDAQ: CMPI) (“Checkmate”), a clinical stage biopharmaceutical company focused…
Basel, 28 April 2021 – Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced that the US Food and Drug Administration…
New Technology Add-on Payment (NTAP) Included in Proposed Fiscal Year 2022 RuleSANTA CLARA, CALIF., April 27, 2021 (GLOBE NEWSWIRE) —…
ROCKVILLE, Md., April 27, 2021 (GLOBE NEWSWIRE) — Supernus Pharmaceuticals, Inc. (Nasdaq: SUPN), a biopharmaceutical company focused on developing and…
London, UK, April 27, 2021 (GLOBE NEWSWIRE) — COMPASS Pathways plc (Nasdaq: CMPS) (“COMPASS”), a mental health care company dedicated…
— Fusogen platform demonstrates potential for cell-specific in vivo delivery of gene therapies to multiple cell types, including T cells…